Drugs / Daclizumub
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00163657 Comparator | Jul 2002 → Apr 2006 | hepatitis C virus infection, liver failure | Baylor Research Institute | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Daclizumub | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00163657 ↗ |